Σφακιανάκης Αλέξανδρος
ΩτοΡινοΛαρυγγολόγος
Αναπαύσεως 5 Άγιος Νικόλαος
Κρήτη 72100
00302841026182
00306932607174
alsfakia@gmail.com

Αρχειοθήκη ιστολογίου

! # Ola via Alexandros G.Sfakianakis on Inoreader

Η λίστα ιστολογίων μου

Σάββατο 6 Μαΐου 2017

Sensitive immunosensing of squamous cell carcinoma antigen based on a nanocomposite of poly{3-amine-N-[3-(N-pyrrole)propyl]imidazole bromide} ionic liquid and gold nanoroots

S09565663.gif

Publication date: 15 October 2017
Source:Biosensors and Bioelectronics, Volume 96
Author(s): Yingying Wu, Yong Zhao, Yanying Wang, Xiaoxue Ye, Tsunghsueh Wu, HongPing Deng, Peng Wu, Chunya Li
Squamous cell carcinoma antigen (SCCA) is a good specific antigen for cancer diagnosis specifically for squamous cell carcinomas. In this study, 3-amine-N-[3-(N-pyrrole)propyl]imidazole bromide (APPIBr) ionic liquid was successfully synthesized and characterized by 1H NMR, HPLC-MS and FTIR. APPIBr ionic liquid is a unique functional material with a pyrrole moiety which can be polymerized by using electrochemical technique and an amine group for immobilizing biomolecules; thus, it is ideal for the fabrication of biosensors. Using chloroauric acid as precursor and N-dodecyl imidazole as functional monomer, gold nanoroots (AuNRs) were fabricated and characterized with TEM, SEM and XRD. An immunosensor was built on a glassy carbon electrode (GCE), through the steps of forming the poly(APPIBr)/AuNRs/GCE interface by electrodeposition of APPIBr, anti-SCCA immobilization, and several optimization steps to achieve a sensitive, accurate, precise, and selective anti-SCCA/poly(APPIBr)/AuNRs/GCE for the electrochemical immunosensing SCCA. It was found that poly(APPIBr)/AuNRs nanointerface can improve the sensing performance of the immunosensor. Under the optimized experimental conditions, there existed two linear regimes relating the peak current variation to the concentration of squamous cell carcinoma antigen in the range of 0.001–0.1ngmL−1 and 0.1–5.0ngmL−1. The detection limit was calculated to be 0.3pgmL−1. The developed sensor was demonstrated its capability in quantitative analysis of squamous cell carcinoma antigen in human serum with recoveries of 97.3%, 102.4% and 107.4%.



http://ift.tt/2pMM8NM

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Αρχειοθήκη ιστολογίου